Vimarsana
Biggest News Aggregation in the World

Page 42 - Biocon Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Biocon Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Biocon Ltd Today - Breaking & Trending Today

Indices: Stock market update: Nifty Pharma index advances 0.06% in an upbeat market - Vimarsana News

Indices: Stock market update: Nifty Pharma index advances 0.06% in an upbeat market

The Nifty Pharma index was trading 0.06 per cent up at 15457.8.

Statin Market to grow by USD 2.67 billion from 2022 to 2027, North America to account for 42% of market growth- Technavio - Vimarsana News

Statin Market to grow by USD 2.67 billion from 2022 to 2027, North America to account for 42% of market growth- Technavio

/PRNewswire/ -- The statin market is expected to grow by USD 2.67 billion from 2022 to 2027. In addition, the momentum of the market will progress at a CAGR of...

Endocrinology drugs market to grow by USD 36.55 billion from 2022 to 2027, North America to account for 45% of market growth- Technavio - Vimarsana News

Endocrinology drugs market to grow by USD 36.55 billion from 2022 to 2027, North America to account for 45% of market growth- Technavio

/PRNewswire/ -- The endocrinology drugs market size is expected to grow by USD 36.55 billion from 2022 to 2027. In addition, the momentum of the market will be...

Biocon chief Kiran Mazumdar Shaw was appointed member of Court of Regents at Royal College of Surgeons, Edinburgh - Vimarsana News

Biocon chief Kiran Mazumdar Shaw was appointed member of Court of Regents at Royal College of Surgeons, Edinburgh

Biocon Ltd and Biocon Biologics Ltd Executive Chairperson Kiran Mazumdar-Shaw has been appointed as Regent of the...

Biocon Biologics completes integration of acquired biosimilars business from Viatris in North America - Vimarsana News

Biocon Biologics completes integration of acquired biosimilars business from Viatris in North America

Bengaluru: Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd, has announced that the Company has completed the integration of the acquired biosimilars business from Viatris in North America...